Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arcus Biosciences Inc
(NY:
RCUS
)
15.80
+0.01 (+0.06%)
Official Closing Price
Updated: 7:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcus Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
51 Biggest Movers From Yesterday
April 06, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 05, 2022
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7...
Via
Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
April 05, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 139% to $5.40 after the company announced that two of its designed mRNA molecules are effective at destroying...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 05, 2022
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares moved upwards by 163.3% to $5.95 during Tuesday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
18 Stocks Moving in Tuesday's Pre-Market Session
April 05, 2022
Gainers System1, Inc. (NYSE: SST) rose 37.5% to $22.70 in pre-market trading as the company reported a 48% year-over-year surge in Q4 sales and issued strong sales forecast....
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 05, 2022
Good morning, investor! It's time to start off another busy day of trading with the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
Arcus Biosciences Announces New Employment Inducement Grants
March 24, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
February 24, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
88 Biggest Movers From Yesterday
February 25, 2022
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...
Via
Benzinga
Recap: Arcus Biosciences Q4 Earnings
February 23, 2022
Arcus Biosciences (NYSE:RCUS) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Arcus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
February 23, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences's Earnings: A Preview
February 22, 2022
Arcus Biosciences (NYSE:RCUS) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
"Prudent" Biotech Bets
February 20, 2022
Here, we review two recommended biotechnology stocks following the release of their latest earnings reports. Let's take a look.
Via
Talk Markets
Arcus Biosciences to Participate in the Upcoming Investor Conferences
February 15, 2022
From
Arcus Biosciences
Via
Business Wire
Earnings Scheduled For February 23, 2022
February 23, 2022
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
February 09, 2022
From
Arcus Biosciences
Via
Business Wire
Gilead Stock Dives After Two Major Charges Dig Into Fourth-Quarter Earnings
February 01, 2022
Gilead shares toppled after hours on lighter-than-expected fourth-quarter profit.
Via
Investor's Business Daily
Arcus Biosciences Announces New Employment Inducement Grants
January 25, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
January 11, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones
January 10, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 04, 2022
Gainers Oncternal Therapeutics (NASDAQ:ONCT
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
December 24, 2021
From
Arcus Biosciences
Via
Business Wire
Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-Stage Programs and New Research Collaboration
December 21, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
December 09, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Why Arcus Biosciences Stock Vaulted Higher in November
December 09, 2021
Arcus was one of the few winners in the turbulent biotech space last month.
Via
The Motley Fool
Taiho Pharmaceutical Exercises Option for an Exclusive License to Arcus Biosciences’ Anti-TIGIT Program in Japan and Certain Territories in Asia
November 30, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference
November 22, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
54 Biggest Movers From Yesterday
November 19, 2021
Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company...
Via
Benzinga
Exposures
Product Safety
Arcus Stock Rockets To Record As Gilead Unexpectedly Opts Into Cancer Drugs
November 18, 2021
Gilead opted into three programs from a small biotech company, sending shares flying.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.